Objective We aimed to investigate the association between the ABO blood groups and the risk of coronary artery disease (CAD) and myocardial infartion (MI) in a young Taiwanese population. Methods We retrospectively recruited 277 consecutive subjects (men younger than 45 years and women younger than 55 years) who underwent coronary angiography (136 with documented CAD and 129 without CAD) at our center, between 2005 and 2008. Their ABO blood groups were determined using standard agglutination techniques. Results Patients with CAD showed a significantly different blood group distribution (O, 30.1%; A, 39.7%; B, 26.5%; AB, 3.7%) than that shown by the controls (O, 42.6%; A, 24.0%; B, 27.1%; AB, 6.2%; p=0.032). Patients with blood group A had a greater risk of CAD and MI than those with non-A blood groups (OR= 2.08, 95% CI=1.23-3.54; OR=2.21, 95% CI=1.19-4.09, respectively). After adjustment for common cardiovascular risk factors such as age, gender, hypertension, cigarette smoking, diabetes mellitus, body mass index, family history of CAD, and lipid profiles; blood group A remained significantly associated with an increased risk of CAD and MI (OR=2.61, 95% CI 1.11-6.14, p=0.028; OR=3.53, 95% CI=1.21-10.29, p= 0.021, respectively). Conclusion Our findings suggest that blood group A is an independent risk factor for CAD and MI in young people in Taiwan.
Introduction
Coronary artery disease (CAD) is a complex disease with multiple risk factors such as sex, age, obesity, cigarette smoking, diabetes mellitus, hypertension, dyslipidemia, and family history (1) . In the last few decades, several reports have shown that the ABO blood groups, particularly the non-O blood groups, are associated with a risk of ischemic heart disease (2) (3) (4) (5) (6) (7) (8) (9) (10) . Results from the Framingham study and other studies have indicated that the incidence of ischemic heart disease may be higher in patients with blood group A than in those with the other blood groups (2-5, 7, 8) . However, studies performed in Finnish and Iranian populations did not show any significant difference in the distributions of the ABO blood groups between patients undergoing coronary artery bypass graft surgery compared to the general population (11, 12) . Furthermore, the findings pertaining to the association between the ABO blood groups and cardiovascular mortality rate have been inconsistent (3, 10, 13) . Although one study has shown the association of blood group A with an increased risk of CAD in women younger than 50 years (14) , no study has focused on the relationship between the ABO blood groups and angiographically verified CAD in young subjects (men younger than 45 years, and women younger than 55 years). The ABO blood groups are genetically transmitted. In most cases, premature CAD may be linked to inheritable risk factors, and the inheritance of the ABO groups could play an important role in the development of premature CAD. We
The First Cardiovascular Division, Department of Internal Medicine, Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Taiwanconducted a retrospective case-control study to evaluate the effect of the ABO blood groups on the risk of CAD, in a young cohort with angiographically verified CAD.
Materials and Methods
This study included 277 consecutive patients (men younger than 45 years and women younger than 55 years), who underwent coronary angiography at the First Cardiovascular Division, Chang Gung Memorial Hospital, Linkou, Taiwan, between 2005 and 2008. The age criteria for enrollment were based on the National Cholesterol Educational Program Adult Treatment Panel III (NCEP-ATPIII) guidelines. These guidelines defined age (men !45 years; women !55 years) as one of the major risk factors for CAD (15) , and younger patients were considered to have early-onset or premature CAD in the GENECARD (Genetics of Early Onset Cardiovascular Disease) (16) and AD-VANCE (Atherosclerotic Disease, Vascular Function, and Genetic Epidemiology) (17) studies. Presence of CAD was defined as >50% stenosis in at least 1 major coronary branch, on coronary angiography. Acute myocardial infarction (AMI) was diagnosed as per the universal definition published in 2007 (18) . Subjects without angiographically demonstrable lesions served as controls (n=138). The controls consisted of subjects with cardiac syndrome X (n=52, 38%), valvular disease (n=39, 28%), heart failure (n=17, 12%), congenital heart disease (n=13, 9%), arrhythmias (n= 9, 7%), and other conditions when knowledge of coronary artery involvement or the presence of CAD necessarily (n=8, 6%). ABO blood groups were determined using standard agglutination techniques. All patients gave written informed consent to the coronary angiography study. The ethics committee at Chang Gung Memorial Hospital approved this study.
Conventional CAD risk factors, such as cigarette smoking, diabetes mellitus, hypertension, dyslipidemia, obesity, and family history of CAD, were recorded for all the study participants. Cigarette smoking was defined as smoking of at least 1 cigarette per day at the time of survey; diabetes mellitus was defined as a fasting plasma glucose !126 mg/ dL, glycohemoglobin value !6.5%, or the use of hypoglycemic agents; hypertension was defined as systolic blood pressure (BP) >140 mmHg and/or diastolic BP >90 mmHg or use of antihypertensive drugs. Family history of CAD was self-reported by the patients and was defined as MI or known CAD in a parent or sibling before the age of 65 years. Lipid profile included total cholesterol (TC), lowdensity lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), and triglyceride (TG). Blood samples for lipid profile were drawn after a 12-hour fast. Obesity was defined as a body mass index (BMI) 27 kg/ m 2 , as per the definition provided by the Department of Health, Taiwan.
Statistical analysis
The Chi-square test (along with Fisher exact test, if necessary) was used to compare categorical variables. The twosample t test or a one-way ANOVA was used to test the continuous variables, and the results were expressed as mean ± SD. Multivariate logistic regression analysis was used to evaluate the independent effect of the investigated variables on the risk of premature CAD and MI. TG values were normalized by logarithmic transformation prior to the statistical analyses. A p value <0.05 (using a two-sided test) was considered statistically significant.
Results

General characteristics
Twelve patients were excluded from this analysis because of the lack of information about the ABO blood groups. Of the 265 study patients, 136 (51%) were diagnosed with CAD and 129 (49%) served as controls, on the basis of the coronary angiography results. Among the CAD patients, 73 experienced an MI, which was clinically verified by electrocardiography (ECG), and developed regional wall motion abnormalities that were detected on left ventriculography or echocardiography. Table 1 lists the characteristics of the CAD patients and the control subjects. The frequencies of classical CAD risk factors, such as male gender, hypertension, diabetes mellitus, obesity, smoking, and family history of CAD were significantly higher in the CAD patients than in the control subjects. The CAD group also had significantly higher values of BMI, TC, TG, TC/HDL-C, and LDL-C/HDL-C; and a significantly lower value of HDL-C. The overall distribution of the ABO groups was also significantly different between the CAD patients and controls (p= 0.032; Table 1 ). Although our controls were from a hospitalized population, the distribution of the ABO groups in the controls was similar to that reported in a large 2010 survey conducted in 1,849,242 volunteer blood donors from among the general Taiwanese population (O, 43.57%; A, 26.65%; B, 23.72%; AB, 6.06%) (19) . The distribution of sex, hypertension, diabetes, obesity, smoking, and family history of CAD and the mean values of age, BMI, HDL-C, TG, TC/ HDL-C, and LDL-C/HDL-C did not differ significantly among the ABO blood groups (Table 2 ). However, subjects with blood group A had significantly higher TC and LDL-C levels than those with blood group O (199±46 mg/dL vs. 179±36 mg/dL, p=0.029 and 124±42 mg/dL vs. 104±29 mg/ dL, p=0.010, respectively; Table 2 ).
CAD and ABO groups
As shown in Table 3 , the frequency of blood group A in subjects in the CAD and MI groups was significantly higher than that in the control subjects (39.7% vs. 24%, p=0.006 and 41.1% vs. 24%, p=0.011, respectively). The frequency of blood group O in the CAD patients was significantly lower than that in the control subjects (30.1% vs. 42.6%, p= 0.035). The frequencies of blood groups B and AB were not significantly different between the CAD/MI and control groups. Similar results were obtained when we compared the CAD patients without MI history (n=63) to the control group (Table 3) . Subjects with blood group A had a greater risk of CAD and MI than did the non-A blood groups (OR= 2.08, 95% CI, 1.23-3.54; and OR=2.21, 95% CI, 1.19-4.09, respectively). Subjects with blood group O were significantly associated with a decreased risk of CAD, not MI (OR=0.58, 95% CI, 0.35-0.96). After adjustment for common cardiovascular risk factors such as age, gender, hypertension, smoking, diabetes, BMI, and family history of CAD; blood group A remained significantly associated with the increased risk of CAD and MI (OR=2.19, 95% CI, 1.07-4.50, p=0.033 and OR=2.90, 95% CI, 1.15-7.31, p=0.024, respectively; Table 4 , 5). Although the lipid profile for the study population was incomplete, the association between the ABO blood groups and CAD was analyzed after adjusting for TC, LDL-C, HDL-C, TG, TC/HDL-C, and LDL-C/ HDL-C levels. Notably, adding lipid profile parameters to the model did not change the outcome (OR=2.61, 95% CI, 1.11-6.14, p=0.028 for CAD and OR=3.53, 95% CI, 1.21-10.29, p=0.021 for MI; Table 4 , 5). These results indicated that influence of blood group A on the susceptibility to CAD/MI is probably independent of these variables. However, because of the small sample size, the association between the ABO blood groups and isolated CAD without MI was insignificant after adjusting for common cardiovascular risk factors and lipid profile (data not shown).
Lastly, there was no consistent relationship between the ABO blood groups and the number of significantly diseased vessels (p=0.849, Table 6 ).
Discussion
In this study, we analyzed the association between the ABO blood groups and angiographically determined CAD in a young Taiwanese population. A significant association was observed between blood group A and an increased risk of CAD, in both univariate and multivariate analyses. Our results suggest that blood group A is an independent risk factor for CAD/MI in Taiwanese men younger than 45 years and women younger than 55 years.
Consistent with previous reports in several populations, including American (2), Norwegian (3), German (4), British (5), Pakistani (6), Hungarian (7), and Italian (10) populations, this study showed an association between blood group A and CAD in a sample of young Taiwanese. The findings of our study are in accordance with those of 2 previous studies that showed that the age of CAD detection and the age of first MI occurrence were lower in patients with blood group A than in those with non-A blood groups (20, 21) . The finding of elevated serum TC in subjects having blood group A was also in agreement with the findings of previous reports (22) (23) (24) (25) (26) . Unlike the control subjects in our study, the control subjects recruited in most of the previously reported studies were not angiographically examined. To the best of our knowledge, this is the first study to focus on a purely young adult population including men and women.
The pathogenic mechanism underlying the association between the ABO blood groups and CAD remains unclear. Interestingly, the ATP-binding cassette 2 (ABCA2) gene, which plays a role in cholesterol homeostasis, and the ABO gene, are both located on chromosome 9q34 (27) . Although subjects with blood group A had significantly higher TC and LDL-C levels than subjects with blood group O, the association of blood group A and CAD/MI was independent of atherogenic lipid profiles. Blood type antigens A and B are expressed not only on the red blood cells but also on other cells such as platelets and vascular endothelial cells (28) . The increased risk of thrombosis in non-O blood groups has been attributed to high plasma levels of the von Willebrand factor (29) (30) (31) (32) . Additionally, genome-wide association studies (GWAS) have identified the ABO gene as a locus for LDL-C metabolism (33); type 2 diabetes (34); and the inflammatory biomarkers soluble E-selectin, P-selectin, and ICAM-1 (34) (35) (36) (37) . Recently, another GWAS also showed that an ABO genetic variant linked to blood group O lowers the risk of MI in patients with angiographically verified CAD (38) . Therefore, blood type antigens may modulate the risk of CAD/MI by influencing the levels of hemostasis and inflammatory proteins in circulation. However, we did not find a significant association between the ABO group and the severity of CAD, which was graded on the basis of the number of significantly diseased vessels. The association between the ABO blood groups and isolated CAD without MI was also insignificant after adjusting for common cardiovascular risk factors and the lipid profile. This could be due to the small sample size and the presence of premature CAD cases, with half of the cases involving only single-vessel disease. Otherwise, the present results imply that an increased risk of thrombosis is more plausible than atheroma progression in explaining the observed association between the ABO blood groups and CAD.
Apart from the intrinsic limitations associated with a retrospective study, the other limitations of the study were single-center design of the study, small sample size, incomplete lipid profile data, and lack of detailed genotype information of the ABO alleles. In addition, the present results may reflect a selection bias, because compared to subjects without CAD who did not undergo coronary angiography, our controls who underwent coronary angiography for heart disease may have differed in factors such as ABO group. The distribution of the ABO groups among our controls is consistent with the general findings among the ethnic Chinese living in South China and Taiwan (19, 39, 40) . However, the association between ABO groups and CAD remained after controlling for a large number of CAD risk factors. Furthermore, there was no reduction in the odds ratio, suggesting that a residual confounding effect is unlikely. We also suggest that analyses with our hospitalized controls might be more preferable than community controls, because coronary angiography has a better accuracy in comparing CAD characteristics between cases and controls. Finally, we did not routinely use the intravascular ultrasound and provocation test to detect early atherosclerosis and determine the presence of coronary artery spasm in our study population. Therefore, a larger, prospective, longitudinal study in which patients are stratified according to the ABO blood group genotypes, plasma levels of lipids, inflammatory markers, hemostasis markers, would be necessary to elucidate the underlying mechanisms by which the ABO groups influence the risk of CAD/MI in Taiwanese and other ethnic populations.
In conclusion, the present findings suggest that blood group A might be an independent risk factor for CAD and AMI in Taiwanese men younger than 45 years and women younger than 55 years. Determination of ABO blood groups might aid in the genetic screening for premature CAD.
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